Related Experiment Video

Updated: Dec 31, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K

miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A

Xiaohan Sun1, Wenrui Xu1, Chuanshan Zang1

  • 1Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.

Oncology Letters
|January 4, 2020
PubMed

Insights

MicroRNA-520c-3p (miRNA-520c-3p) is downregulated in nasopharyngeal carcinoma (NPC), suppressing tumor growth. This microRNA accelerates NPC progression by targeting RAB22A, offering potential therapeutic insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Nasopharyngeal carcinoma (NPC) is a significant head and neck cancer.
  • MicroRNAs play crucial roles in cancer development and progression.
  • The specific role of microRNA-20c-3p (miRNA-520c-3p) in NPC remains to be fully elucidated.

Purpose of the Study:

  • To investigate the biological function of miRNA-520c-3p in NPC progression.
  • To identify the underlying molecular mechanism involving miRNA-520c-3p in NPC.
  • To explore miRNA-520c-3p as a potential biomarker or therapeutic target for NPC.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to assess miRNA-520c-3p levels in NPC tissues and cell lines.
  • Cell counting kit-8 (CCK-8) and flow cytometry to evaluate the impact of miRNA-520c-3p on NPC cell proliferation and cell cycle.
  • Dual-luciferase reporter gene assay to verify the direct target gene of miRNA-520c-3p.

Main Results:

  • miRNA-520c-3p was significantly downregulated in NPC tissues and cell lines compared to normal controls.
  • Lower miRNA-520c-3p levels correlated with advanced tumor stage and larger tumor size in NPC patients.
  • Overexpression of miRNA-520c-3p inhibited NPC cell proliferation and induced G0/G1 cell cycle arrest.
  • RAB22A was identified as a direct downstream target of miRNA-520c-3p and was upregulated in NPC.
  • Overexpression of RAB22A rescued the inhibitory effects of miRNA-520c-3p on NPC cell growth and cell cycle progression.

Conclusions:

  • miRNA-520c-3p functions as a tumor suppressor in nasopharyngeal carcinoma.
  • The downregulation of miRNA-520c-3p contributes to NPC malignant progression by upregulating its target gene, RAB22A.
  • miRNA-520c-3p/RAB22A axis represents a potential therapeutic target for NPC treatment.
Keywords:
RAB22Acell cyclemiRNA-520c-3pnasopharyngeal carcinomaproliferation

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.9K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K